gptkbp:instanceOf
|
gptkb:Company
|
gptkbp:acquisition
|
Acquired_by_Johnson_&_Johnson_in_2000
|
gptkbp:employees
|
Approximately 1,000
|
gptkbp:founded
|
1959
|
gptkbp:founder
|
Robert_McNeil
|
gptkbp:headquarters
|
gptkb:Fort_Washington,_Pennsylvania
|
https://www.w3.org/2000/01/rdf-schema#label
|
McNeil Consumer Healthcare
|
gptkbp:industry
|
Pharmaceuticals
|
gptkbp:keyPeople
|
gptkb:David_J._McNeil
gptkb:Robert_J._McNeil
gptkb:William_J._McNeil
gptkb:Jorge_Mesquita
gptkb:Michael_S._D._McNeil
|
gptkbp:notableFeature
|
gptkb:Mylanta_Maximum_Strength
Tylenol Extra Strength
Tylenol PM
Benadryl Allergy
Motrin IB
Zyrtec Allergy
Pepto-Bismol Liquid
|
gptkbp:parentCompany
|
gptkb:Johnson_&_Johnson
|
gptkbp:products
|
gptkb:Mylanta
Benadryl
Tylenol
Motrin
Pepto-Bismol
Zyrtec
|
gptkbp:recalls
|
Benadryl recall in 2010
Motrin recall in 2010
Tylenol recall in 2009
Zyrtec recall in 2011
Pepto-Bismol_recall_in_2015
|
gptkbp:region
|
gptkb:Asia
gptkb:Latin_America
gptkb:North_America
Europe
Global
|
gptkbp:revenue
|
$1 billion (approx.)
|
gptkbp:subsidiary
|
gptkb:Johnson_&_Johnson
|
gptkbp:sustainabilityInitiatives
|
Community health initiatives
Environmental sustainability programs
Product safety improvements
|
gptkbp:website
|
www.mcneilconsumerhealthcare.com
|